In AML, we have shown that MNX1 interacts with methyl transferases and components of the methionine cycle, leading to extensive histone modifications, particularly H3K4me3 and H3K27me3, which in turn result in aberrant gene expression, widespread chromatin alterations, and DNA damage5. The gene discussed is MNX1; the disease is acute myeloid leukemia.